Literature DB >> 24900618

Influenza RNA-Dependent RNA Polymerase (RdRp) Inhibitors: Potential New Therapy for Influenza Treatment.

Ahmed F Abdel-Magid1.   

Abstract

Year:  2013        PMID： 24900618      PMCID： PMC4027449          DOI： 10.1021/ml400411e

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

1.  Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.

Authors:  Michael P Malakhov; Laura M Aschenbrenner; Donald F Smee; Miles K Wandersee; Robert W Sidwell; Larisa V Gubareva; Vasiliy P Mishin; Frederick G Hayden; Do Hyong Kim; Alice Ing; Erin R Campbell; Mang Yu; Fang Fang
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

2.  Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice.

Authors:  Donald F Smee; Brett L Hurst; Min-Hui Wong; Kevin W Bailey; E Bart Tarbet; John D Morrey; Yousuke Furuta
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

3.  Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.

Authors:  Sachiko Seo; Janet A Englund; Jack T Nguyen; Sasithon Pukrittayakamee; Niklas Lindegardh; Joel Tarning; Paul A Tambyah; Christian Renaud; Gregory T Went; Menno D de Jong; Michael J Boeckh
Journal:  Antivir Ther       Date:  2012-12-21

4.  Antiviral strategies for pandemic and seasonal influenza.

Authors:  Maria Hedlund; Jeffrey L Larson; Fang Fang
Journal:  Viruses       Date:  2010-08-20       Impact factor: 5.818
  4 in total
  2 in total

Review 1.  The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design.

Authors:  Annelies Stevaert; Lieve Naesens
Journal:  Med Res Rev       Date:  2016-08-29       Impact factor: 12.944

Review 2.  Progress of small molecular inhibitors in the development of anti-influenza virus agents.

Authors:  Xiaoai Wu; Xiuli Wu; Qizheng Sun; Chunhui Zhang; Shengyong Yang; Lin Li; Zhiyun Jia
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.